Imperial College London Featured PhD Programmes
Gdansk University of Technology Featured PhD Programmes
University of Reading Featured PhD Programmes

monoclonal antibodies PhD Projects, Programmes & Scholarships

We have 14 monoclonal antibodies PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


We have 14 monoclonal antibodies PhD Projects, Programmes & Scholarships

PhD saved successfully

Precise, peptide-directed loading of drugs onto therapeutic antibodies for targeted imaging and treatment of tumors.

The PhD project aims to develop a non-covalent technology for loading small molecules and therapeutic enzymes onto monoclonal antibodies thus addressing issues in preparations of antibody-drug conjugates, such as poor yields and non-specific conjugation of the drugs resulting in compromised immunoaffinity. Read more

Unlocking new drug targets through antibody-targeted protein degradation

Supervisors. Professor Ed Tate (ICL). Dr Paul Hogg (ADCT, White City). Dr Francesca Zammarchi (ADCT, White City). Targeting protein degradation with Proteolysis-Targeting Chimeras (PROTACs) is an area of great current interest in drug discovery. Read more

MSc by Research: Immunotherapy against trypanosomiasis: Proof of concept

Drug discovery for parasitic diseases remains a major challenge and global health need. Significant advances in screening technology and methods to understand the mode of action in the past decade have contributed hugely to our arsenal of biological tools to control these pathogens. Read more

Understanding the Stability of Biologics Using Advanced Light Scattering Techniques

The biotherapeutics market was valued at approximately USD 325.17 billion in 2020. It is expected to witness a revenue of USD 496.71 billion in 2026, with a CAGR of 7.32% over the forecast period, 2021-2026. Read more

Biological significance, predictive value and targeting of cell surface antigens in colorectal cancer.

Despite major advances in its early detection, preventive measures and therapeutic options, colorectal cancer is the fourth most commonly diagnosed cancer and the third leading cause of cancer deaths worldwide. Read more
  • 1

Filtering Results